Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2017-09, Vol.28, p.v418-v418 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | v418 |
|---|---|
| container_issue | |
| container_start_page | v418 |
| container_title | Annals of oncology |
| container_volume | 28 |
| creator | Stanczak, P.S. Grzybowski, M.M. Wolska, P. Zdziarska, A.M. Mazurkiewicz, M. Blaszczyk, R. Nowicka, J. Sosnowska, A. Ramji, K. Nowis, D. Golab, J. Golebiowski, A. Dobrzanski, P. Dzwonek, K. |
| description | |
| doi_str_mv | 10.1093/annonc/mdx376.045 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdx376_045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753420384477</els_id><sourcerecordid>S0923753420384477</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1855-c7b1de0de5d608544e84a3b748cc0a7ec3582bbb1a0510ddafbb84339231e9833</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EEqXwAez8AaTYsZ04YlWVp1Spm7K2_JhQo8au7FDRv8corFmMZjE6V3MPQreULCjp2L0OIQZ7P7hv1jYLwsUZmlHRdJUknJ6jGelqVrWC8Ut0lfMnIaTp6m6Gto9whH08DBBGHHu8WW4r2vLmDmscYjlhnT580BkwxTo4XGMfdt74MSbcl7E6WEjYD8NXiOMOkj6crtFFr_cZbv72HL0_P21Xr9V68_K2Wq4rS6UQlW0NdUAcCNcQKTgHyTUzLZfWEt2CZULWxhiqiaDEOd0bIzljpQqFTjI2R3TKtSnmnKBXh-QHnU6KEvWrRU1a1KRFFS2FeZgYKI8dPSSVrYfSwfkEdlQu-n_oH1WsbJQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Stanczak, P.S. ; Grzybowski, M.M. ; Wolska, P. ; Zdziarska, A.M. ; Mazurkiewicz, M. ; Blaszczyk, R. ; Nowicka, J. ; Sosnowska, A. ; Ramji, K. ; Nowis, D. ; Golab, J. ; Golebiowski, A. ; Dobrzanski, P. ; Dzwonek, K.</creator><creatorcontrib>Stanczak, P.S. ; Grzybowski, M.M. ; Wolska, P. ; Zdziarska, A.M. ; Mazurkiewicz, M. ; Blaszczyk, R. ; Nowicka, J. ; Sosnowska, A. ; Ramji, K. ; Nowis, D. ; Golab, J. ; Golebiowski, A. ; Dobrzanski, P. ; Dzwonek, K.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdx376.045</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2017-09, Vol.28, p.v418-v418</ispartof><rights>2017 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1855-c7b1de0de5d608544e84a3b748cc0a7ec3582bbb1a0510ddafbb84339231e9833</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Stanczak, P.S.</creatorcontrib><creatorcontrib>Grzybowski, M.M.</creatorcontrib><creatorcontrib>Wolska, P.</creatorcontrib><creatorcontrib>Zdziarska, A.M.</creatorcontrib><creatorcontrib>Mazurkiewicz, M.</creatorcontrib><creatorcontrib>Blaszczyk, R.</creatorcontrib><creatorcontrib>Nowicka, J.</creatorcontrib><creatorcontrib>Sosnowska, A.</creatorcontrib><creatorcontrib>Ramji, K.</creatorcontrib><creatorcontrib>Nowis, D.</creatorcontrib><creatorcontrib>Golab, J.</creatorcontrib><creatorcontrib>Golebiowski, A.</creatorcontrib><creatorcontrib>Dobrzanski, P.</creatorcontrib><creatorcontrib>Dzwonek, K.</creatorcontrib><title>Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EEqXwAez8AaTYsZ04YlWVp1Spm7K2_JhQo8au7FDRv8corFmMZjE6V3MPQreULCjp2L0OIQZ7P7hv1jYLwsUZmlHRdJUknJ6jGelqVrWC8Ut0lfMnIaTp6m6Gto9whH08DBBGHHu8WW4r2vLmDmscYjlhnT580BkwxTo4XGMfdt74MSbcl7E6WEjYD8NXiOMOkj6crtFFr_cZbv72HL0_P21Xr9V68_K2Wq4rS6UQlW0NdUAcCNcQKTgHyTUzLZfWEt2CZULWxhiqiaDEOd0bIzljpQqFTjI2R3TKtSnmnKBXh-QHnU6KEvWrRU1a1KRFFS2FeZgYKI8dPSSVrYfSwfkEdlQu-n_oH1WsbJQ</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Stanczak, P.S.</creator><creator>Grzybowski, M.M.</creator><creator>Wolska, P.</creator><creator>Zdziarska, A.M.</creator><creator>Mazurkiewicz, M.</creator><creator>Blaszczyk, R.</creator><creator>Nowicka, J.</creator><creator>Sosnowska, A.</creator><creator>Ramji, K.</creator><creator>Nowis, D.</creator><creator>Golab, J.</creator><creator>Golebiowski, A.</creator><creator>Dobrzanski, P.</creator><creator>Dzwonek, K.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201709</creationdate><title>Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy</title><author>Stanczak, P.S. ; Grzybowski, M.M. ; Wolska, P. ; Zdziarska, A.M. ; Mazurkiewicz, M. ; Blaszczyk, R. ; Nowicka, J. ; Sosnowska, A. ; Ramji, K. ; Nowis, D. ; Golab, J. ; Golebiowski, A. ; Dobrzanski, P. ; Dzwonek, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1855-c7b1de0de5d608544e84a3b748cc0a7ec3582bbb1a0510ddafbb84339231e9833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stanczak, P.S.</creatorcontrib><creatorcontrib>Grzybowski, M.M.</creatorcontrib><creatorcontrib>Wolska, P.</creatorcontrib><creatorcontrib>Zdziarska, A.M.</creatorcontrib><creatorcontrib>Mazurkiewicz, M.</creatorcontrib><creatorcontrib>Blaszczyk, R.</creatorcontrib><creatorcontrib>Nowicka, J.</creatorcontrib><creatorcontrib>Sosnowska, A.</creatorcontrib><creatorcontrib>Ramji, K.</creatorcontrib><creatorcontrib>Nowis, D.</creatorcontrib><creatorcontrib>Golab, J.</creatorcontrib><creatorcontrib>Golebiowski, A.</creatorcontrib><creatorcontrib>Dobrzanski, P.</creatorcontrib><creatorcontrib>Dzwonek, K.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stanczak, P.S.</au><au>Grzybowski, M.M.</au><au>Wolska, P.</au><au>Zdziarska, A.M.</au><au>Mazurkiewicz, M.</au><au>Blaszczyk, R.</au><au>Nowicka, J.</au><au>Sosnowska, A.</au><au>Ramji, K.</au><au>Nowis, D.</au><au>Golab, J.</au><au>Golebiowski, A.</au><au>Dobrzanski, P.</au><au>Dzwonek, K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy</atitle><jtitle>Annals of oncology</jtitle><date>2017-09</date><risdate>2017</risdate><volume>28</volume><spage>v418</spage><epage>v418</epage><pages>v418-v418</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdx376.045</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2017-09, Vol.28, p.v418-v418 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdx376_045 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T16%3A04%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20OAT-1746,%20a%20novel%20arginase%201%20and%202%20inhibitor%20for%20cancer%20immunotherapy&rft.jtitle=Annals%20of%20oncology&rft.au=Stanczak,%20P.S.&rft.date=2017-09&rft.volume=28&rft.spage=v418&rft.epage=v418&rft.pages=v418-v418&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdx376.045&rft_dat=%3Celsevier_cross%3ES0923753420384477%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753420384477&rfr_iscdi=true |